Grossi Federico 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jun 2, 2022
Insider Transaction Report
Form 4
Grossi Federico
See Remarks
Transactions
- Sale
Common Stock
2022-06-01$41.78/sh−2,500$104,450→ 109,561 total
Footnotes (1)
- [F1]This is a scheduled sale from 10B5-1 trading plan.